AC
VTYX

Avestar Capital’s Ventyx Biosciences VTYX Stock Holding History

Avestar Capital’s Portfolio VTYX Stock Details VTYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-11,412
Closed -$103K – 558
2025
Q4 		$103K Hold
11,412
– – 0.01% 471
2025
Q3 		$35.5K Hold
11,412
– – ﹤0.01% 477
2025
Q2 		$24.4K Hold
11,412
– – ﹤0.01% 491
2025
Q1 		$13.1K Hold
11,412
– – ﹤0.01% 484
2024
Q4 		$25K Hold
11,412
– – ﹤0.01% 518
2024
Q3 		$24.9K Hold
11,412
– – ﹤0.01% 468
2024
Q2 		$26.4K Hold
11,412
– – ﹤0.01% 451
2024
Q1 		$62.8K Hold
11,412
– – 0.01% 453
2023
Q4 		$28.2K Hold
11,412
– – ﹤0.01% 388
2023
Q3 		$396K Buy
11,412
+1,033
+10% +$35.7K 0.06% 196
2023
Q2 		$340K Buy
10,379
+2,910
+39% +$100K 0.05% 206
2023
Q1 		$250K Buy
7,469
+1,000
+15% +$38.9K 0.04% 263
2022
Q4 		$212K Buy
+6,469
New +$192K 0.04% 268

Other funds holding VTYX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Avestar Capital's VTYX Position: Q1 2026 in Review

Avestar Capital sold out of Ventyx Biosciences (VTYX) in Q1 2026, closing a stake of 11,412 shares — an estimated $103K sold.

Avestar Capital first reported a position in VTYX in Q4 2022 and held it in 13 quarters. The position peaked at $396K in Q3 2023. 1 fund tracked by Wall St. Rank holds VTYX as of Q1 2026.

  • Avestar Capital reported no remaining Ventyx Biosciences position as of Q1 2026 after selling out during the quarter.
  • Avestar Capital sold 11,412 Ventyx Biosciences shares in Q1 2026, an estimated $103K.
  • Avestar Capital first reported a position in Ventyx Biosciences in Q4 2022 and held it in 13 quarters.
  • Avestar Capital's Ventyx Biosciences position peaked at $396K in Q3 2023.
  • 1 fund tracked by Wall St. Rank held Ventyx Biosciences as of Q1 2026.

Based on Avestar Capital's 13F filing for Q1 2026, filed 13 May 2026.